Considering all 103 multiple myeloma treated patients, the overall response rate (ORR) was 60%, and 29% of patients achieved at least a very good partial response (VGPR), defined as a > 90% reduction in serum M-protein (Table 2, Figure 4). This evidence concerns the gene MYOM2 and AL amyloidosis.